Mancozeb poisoning treatment??
mancozeb poisoning treatment management clinical
mancozeb dithiocarbamate poisoning treatment
| Route | Effect |
|---|---|
| Acute ingestion/inhalation | GI irritation, CNS depression |
| ETU metabolite | Thyroid disruption (antithyroid effect), hepatotoxicity, potential carcinogenesis |
| Manganese component | Neurotoxicity with chronic exposure (parkinsonism-like syndrome) |
| Skin/Eye | Contact dermatitis, irritation |
| Issue | Management |
|---|---|
| NOT a cholinesterase inhibitor | Atropine and pralidoxime (2-PAM) are NOT indicated |
| Thyroid suppression | Monitor TFTs; thyroid hormone replacement if hypothyroidism develops |
| Manganese toxicity (chronic) | Chelation with Na₂CaEDTA has been used; levodopa for parkinsonism symptoms |
| Hepatotoxicity | N-acetylcysteine (NAC) may be used as a hepatoprotectant |
| Skin sensitization/dermatitis | Topical corticosteroids; antihistamines |
⚠️ Mancozeb ≠ organophosphate/carbamate insecticide. Atropine and pralidoxime are NOT part of treatment.
⚠️ ETU (metabolite) causes thyroid toxicity — monitor TFTs especially in subacute/chronic exposure.
⚠️ No specific antidote — management is decontamination + supportive care.